Search research articles
Contact Us
Filters
Showing results (361-370 of 484) with videos related to
Page
of 49
Sort By:
Arthritis Research & Therapy
|
January 27, 2011
mPGES-1 null mice are resistant to bleomycin-induced skin fibrosis
Matthew R McCann, Roxana Monemdjou, Parisa Ghassemi-Kakroodi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
January 8, 2019
Reduced Right Ventricular Output Reserve in Patients With Systemic Sclerosis and Mildly Elevated Pulmonary Artery Pressure
Christian Nagel, Alberto M Marra, Nicola Benjamin, et al.
Rheumatology (Oxford, England)
|
February 17, 2022
Nailfold capillaroscopy in SSc: innocent bystander or promising biomarker for novel severe organ involvement/progression?
Amber Vanhaecke, Maurizio Cutolo, Oliver Distler, et al.
Annals of the Rheumatic Diseases
|
May 21, 2013
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study
J Gerry Coghlan, Christopher P Denton, Ekkehard Grünig, et al.
The Journal of Rheumatology
|
March 17, 2020
Analysis of Anti-RNA Polymerase III Antibody-positive Systemic Sclerosis and Altered GPATCH2L and CTNND2 Expression in Scleroderma Renal Crisis
Edward P Stern, Sandra G Guerra, Harry Chinque, et al.
The Lancet. Respiratory Medicine
|
September 1, 2020
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
Dinesh Khanna, Celia J F Lin, Daniel E Furst, et al.
The Journal of Biological Chemistry
|
February 15, 2005
Activation of key profibrotic mechanisms in transgenic fibroblasts expressing kinase-deficient type II Transforming growth factor-{beta} receptor (T{beta}RII{delta}k)
Christopher P Denton, Gisela E Lindahl, Korsa Khan, et al.
The Journal of Rheumatology
|
October 4, 2011
Analysis of the validation status of quality of life and functional disability measures in pulmonary arterial hypertension related to systemic sclerosis: results of a systematic literature analysis by the Expert Panel on Outcomes Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS)
Otylia Kowal-Bielecka, Jerome Avouac, David Pittrow, et al.
Clinical and Experimental Rheumatology
|
June 26, 2010
Interactions between rheumatologists and cardio-/pulmonologists in the assessment and use of outcome measures in pulmonary arterial hypertension related to systemic sclerosis
Doerte Huscher, David Pittrow, Oliver Distler, et al.
The Journal of Rheumatology
|
November 17, 2018
Preliminary Validation of the Digital Ulcer Clinical Assessment Score in Systemic Sclerosis
Cosimo Bruni, Tanaka Ngcozana, Francesca Braschi, et al.
Page
of 49
Search research articles
Search
Showing results (361-370 of 484) with videos related to
Sort By:
Page
of 49
Arthritis Research & Therapy
|
January 27, 2011
mPGES-1 null mice are resistant to bleomycin-induced skin fibrosis
Matthew R McCann, Roxana Monemdjou, Parisa Ghassemi-Kakroodi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
January 8, 2019
Reduced Right Ventricular Output Reserve in Patients With Systemic Sclerosis and Mildly Elevated Pulmonary Artery Pressure
Christian Nagel, Alberto M Marra, Nicola Benjamin, et al.
Rheumatology (Oxford, England)
|
February 17, 2022
Nailfold capillaroscopy in SSc: innocent bystander or promising biomarker for novel severe organ involvement/progression?
Amber Vanhaecke, Maurizio Cutolo, Oliver Distler, et al.
Annals of the Rheumatic Diseases
|
May 21, 2013
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study
J Gerry Coghlan, Christopher P Denton, Ekkehard Grünig, et al.
The Journal of Rheumatology
|
March 17, 2020
Analysis of Anti-RNA Polymerase III Antibody-positive Systemic Sclerosis and Altered GPATCH2L and CTNND2 Expression in Scleroderma Renal Crisis
Edward P Stern, Sandra G Guerra, Harry Chinque, et al.
The Lancet. Respiratory Medicine
|
September 1, 2020
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
Dinesh Khanna, Celia J F Lin, Daniel E Furst, et al.
The Journal of Biological Chemistry
|
February 15, 2005
Activation of key profibrotic mechanisms in transgenic fibroblasts expressing kinase-deficient type II Transforming growth factor-{beta} receptor (T{beta}RII{delta}k)
Christopher P Denton, Gisela E Lindahl, Korsa Khan, et al.
The Journal of Rheumatology
|
October 4, 2011
Analysis of the validation status of quality of life and functional disability measures in pulmonary arterial hypertension related to systemic sclerosis: results of a systematic literature analysis by the Expert Panel on Outcomes Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS)
Otylia Kowal-Bielecka, Jerome Avouac, David Pittrow, et al.
Clinical and Experimental Rheumatology
|
June 26, 2010
Interactions between rheumatologists and cardio-/pulmonologists in the assessment and use of outcome measures in pulmonary arterial hypertension related to systemic sclerosis
Doerte Huscher, David Pittrow, Oliver Distler, et al.
The Journal of Rheumatology
|
November 17, 2018
Preliminary Validation of the Digital Ulcer Clinical Assessment Score in Systemic Sclerosis
Cosimo Bruni, Tanaka Ngcozana, Francesca Braschi, et al.
Page
of 49